V-Wave
Herstellung medizinischer Geräte
Caesarea, Israel 4,701 followers
Advancing the flow of life
Über uns
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF). As a leading cause of death and hospitalization, HF continues to affect millions of people worldwide. V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
- Website
-
http://vwavemedical.com/
External link for V-Wave
- Industrie
- Herstellung medizinischer Geräte
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- Caesarea, Israel
- Typ
- In Privatbesitz
- Spezialitäten
- Medical Devices, Heart Failure, LAP Regulation, and Cardiology
Standorte
-
Primäre
Wegbeschreibung erhalten
15 Halamish St.
Caesarea, Israel 3079579, IL
-
Wegbeschreibung erhalten
29229 Canwood Street
Suite 200
Agoura Hills, California 91301, US
Employees at V-Wave
Aktualisierungen
-
We look forward to attending this year’s #ACC24 and to Dr. Gregg Stone’s presentation of the late-breaking data from our pivotal RELIEVE-HF clinical study in patients with heart failure. To learn more, be sure to read our press release: https://lnkd.in/gtsAzwhe
-
-
V-Wave is exhibiting at #HFSA2023 - where #heartfailure teams gather! Come meet our team at booth 326
-
We are at DGK Heart Days in Bonn, Germany. Please stop by booth number 121 to say hello to our team and to learn more about The Ventura® Interatrial Shunt*. Wir sind auf den DGK-Herztagen in Bonn. Bitte schauen Sie am Stand Nr. 121 vorbei, um unserem Team Hallo zu sagen und mehr über den Ventura® Interatrial Shunt* zu erfahren. *CE mark (0344): The V-Wave® Ventura® Interatrial Shunt is a permanent implant, which is designed to treat symptomatic heart failure by shunting blood across the interatrial septum
-
-
V-Wave is a proud sponsor of #HFSA2023! Meet us at booth 326 in Cleveland, OH from October 6-9 as we connect with the leading experts in #heartfailure. Register at: hfsa.org/asm2023
-